from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2253/-

LFCtreatmentdescriptionclass of inhibitor

1.710

Amikacinug/mL Amikacintranslation

2.275

Cap5-10ug/mL Capreomycintranslation

2.206

Rox10-50 ug/mL Roxithromycintranslation

0.027

SM2-5 ug/mL Streptomycintranslation

2.546

Tet5-10 ug/mL Tetracyclinetranslation

0.196

Rif0.2-5ug/mL Rifampicintranscription

0.643

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.642

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.412

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.382

CPZ10-50 ug/mL Chlorpromazinerespiration

0.202

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.984

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.217

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.344

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.601

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.186

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.242

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.454

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.311

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.207

KCN5-20 ug/mL Potassium cyaniderespiration

-3.477

NaN30.2-2 mM Sodium aziderespiration

3.881

Nigericin50 uM Nigericinrespiration

0.251

TRC10-150 ug/mL Triclosanrespiration

-0.023

TRZ10-25 ug/mL Thioridazinerespiration

0.763

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.085

menadione6-10 ug/mL Menadionerespiration

-0.514

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.184

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.101

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.517

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.450

NRP_1Non-replicating persistence stage 1dosRassociated

0.042

Amp0.2mg/mL AmpicillincellWall

-0.160

Cephalexin20-100 ug/mL CephalexincellWall

0.491

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.034

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.323

EMB10-20 ug/mL EthambutolcellWall

0.292

Eta12-40 ug/mL EthionamidecellWall

0.111

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.152

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.269

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.142

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.073

BZA0.12 mg/mL BenzamidearomaticAmides

0.186

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.242

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.050

H2O24 mM hydrogen peroxideDNAdamaging

0.090

Levo10 ug/mL LevofloxacinDNAdamaging

-0.372

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.768

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.135

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.333

UVUV-irradiationDNAdamaging

-0.115

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.086

Antimycin12.5-50 ug/mL Antimycin A?

0.553

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.892

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.392

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.719

PA8240.2-2 ug/mL PA-824?

-0.834

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.539

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.185

Verapamil50 uM Verapamil?

1.701

mercaptoethanol2 mM 2-Mercaptoethanol?

0.541

methoxatin10-20 ug/mL Methoxatin?